SYROSINGOPINE

SYROSINGOPINE

Application

Syrosingopine has been used as a monocarboxylate transporter (MCT) inhibitorto study its effects on anti-CD147-induced metabolon disruption in human breast cancer cellsto study its effects on Cryptosporidium parvum-infected HCT-8 cellsin orthogonal linear separation analysis (OLSA)-derived decomposed analysis

Biochem/physiol Actions

Syrosingopine is an antihypertensive agent related to reserpine that was found to potentiate the anticancer effects of the antidiabetic agent metformin and phenformin without harmful effects on normal cells. Syrosingopine was also found to potentiate the anticancer activity of mitochondrial electron transport chain (ETC) inhibitors. Its mechanism of action is currently unknown but may involve inhibition of glycolytic enzyme α-enolase rather than its known activity as an inhibitor of vesicular monoamine transporters VMAT1 and VMAT2.

Syrosingopine is a derivative of reserpine and inhibits monocarboxylate lactate transporters 1 and 4 (MCT1/4).

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour Quality Level InChI key InChI Manufacturer Solubility Form Price Quantity
3575533 SYROSINGOPINE white to light brown 100 ZCDNRPPFBQDQHR-SSYATKPKSA-N 1S/C35H42N2O11/c1-7-46-35(40)48-31-26(42-3)12-18(13-27(31)43-4)33(38)47-28-14-19-17-37-11-10-22-21-9-8-20(41-2)15-24(21)36-30(22)25(37)16-23(19)29(32(28)44-5)3 SIGMA-ALDRICH DMSO: 10 mg/mL, clear powder
£490.29 (exc VAT) per 25MG
-
+
3575534 SYROSINGOPINE white to light brown 100 ZCDNRPPFBQDQHR-SSYATKPKSA-N 1S/C35H42N2O11/c1-7-46-35(40)48-31-26(42-3)12-18(13-27(31)43-4)33(38)47-28-14-19-17-37-11-10-22-21-9-8-20(41-2)15-24(21)36-30(22)25(37)16-23(19)29(32(28)44-5)3 SIGMA-ALDRICH DMSO: 10 mg/mL, clear powder
£150.43 (exc VAT) per 5MG
-
+